Title of article
Ineffectiveness of myrrh-derivative Mirazid against schistosomiasis and fascioliasis in humans
Author/Authors
Osman, M.M. University of Alexandria - Medical Research Institute - Department of Parasitology, Egypt , El-Taweel, H.A. University of Alexandria - Medical Research Institute - Department of Parasitology, Egypt , Shehab, A.Y. University of Alexandria - Medical Research Institute - Department of Parasitology, Egypt , Farag, H.F. University of Alexandria - Medical Research Institute - Department of Parasitology, Egypt
From page
932
To page
936
Abstract
The present study assessed the schistosomicidal and fasciolicidal actions of the myrrh-derivative Mirazid® in an area of low schistosomiasis transmission. A total of 27 patients infected with Schistosoma mansoni and 16 with Fasciola spp. received the maximum recommended dose of Mirazid. Pretreatment egg counts in 4 Kato–Katz slides were compared with similar counts in stool samples collected 1 and 2 months after treatment. Standard procedures and quality control measures were followed. The results revealed that Mirazid used as schistosomicidal or fasciolicidal agent in the maximum recommended dose has a low cure rate and produced a negligible reduction in egg counts. Prescribing such an ineffective drug in Egypt might endanger the achievements of the schistosomiasis control strategy.
Journal title
Eastern Mediterranean Health Journal
Journal title
Eastern Mediterranean Health Journal
Record number
2641748
Link To Document